In comparison, exogenous protein targeting has allowed identification of several biomarkers which are overexpressed in many types of cancer such as the cell surface receptors EGFR and VEGFR [13–17] which have been studied as targets for therapeutic drug delivery [18–20] and diagnostic imaging [21–23]. This evidence concerns the gene EGFR and cancer.